Collecting duct carcinoma
Other Names for this Disease
- Collecting duct carcinoma of the kidney
- Renal collecting duct carcinoma
- Bellini’s duct carcinoma
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Treatment of collecting duct carcinoma (CDC) may include surgery to remove the kidney. Chemotherapy may also be given. The authors of a 2013 review article mentioned that gemcitabine and cisplatin should be considered the standard of care for chemotherapy treatment of metastatic CDC. This treatment regimen is similar to what is given for transitional cell carcinoma, also known as urothelial carcinoma. Immunotherapy was not shown to be effective in treating CDC. There are a few reports of promising results from targeted therapy such as sunitinib or sorafenib. Studies are underway to learn more about these treatment options.
Last updated: 3/28/2016
- Dason S, Allard C, Sheridan-Jonah A, Gill J, Jamshaid H, Aziz T, Kajal B, Kapoor A. Management of renal collecting duct carcinoma: a systematic review and the McMaster experience. Current Oncology. June 2013; 20(3):e223-32. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671029.
- Finding Treatment Information - A video developed by GARD Information Specialists that explains how you can find information about treatment for a rare disease.
- ClinicalTrials.gov lists trials that are studying or have studied Collecting duct carcinoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.